Anya is a junior doctor working in the NHS, soon to start training in psychiatry. She has worked as a clinical research fellow at the UCL Clinical Psychopharmacology Unit, investigating effects of recreational cannabis use and on a clinical trial of ketamine. Anya coordinated an fMRI study of THC/THC+CBD to examine the acute effects in adolescents versus adults and has worked on a longitudinal study of the effects of recreational cannabis use in adolescents versus adults (https://www.ucl.ac.uk/psychopharmacology/trials/cannteen). Prior to that, she has also worked on a clinical trial of ketamine for people with alcohol use disorder (https://psychology.exeter.ac.uk/kare/).
Anya Borissova summarises the therapeutic mechanisms of psilocybin in treatment-resistant depression and changes noticed in the amygdala and prefrontal cortex during emotional processing.[read the full story...]
Anya Borissova summarises a recent systematic review which brings together all of the randomised controlled trials of LSD as a treatment for mental illnesses, including alcohol and heroin dependency, depression and anxiety.[read the full story...]